The fertility assist device called INVOcell has received market approval in the EU.

Meant to replace the artificial in vitro fertilization (IVF) lab with a natural maternal environment to optimize early embryo development, is where INVOcell comes in - a product of BioXcell.

The device, an incubator designed to hold a postfertilization oocyte(s), is placed into the maternal vaginal cavity. The idea is to replace the artificial in vitro fertilization (IVF) lab with a natural maternal environment to optimize early embryo development inside the INVOcell device.

Story found via MedGadget (read more).